Aurora Cannabis Inc. (NASDAQ:ACB) Short Interest Update

Aurora Cannabis Inc. (NASDAQ:ACB) was the recipient of a large decrease in short interest in the month of September. As of September 30th, there was short interest totalling 2,590,000 shares, a decrease of 5.1% from the September 15th total of 2,730,000 shares. Based on an average daily volume of 1,280,000 shares, the days-to-cover ratio is currently 2.0 days. Currently, 4.8% of the shares of the company are short sold.

Institutional Trading of Aurora Cannabis

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Virtu Financial LLC purchased a new position in shares of Aurora Cannabis during the 1st quarter worth approximately $727,000. TD Asset Management Inc purchased a new position in shares of Aurora Cannabis during the 2nd quarter worth approximately $255,000. Headlands Technologies LLC purchased a new position in shares of Aurora Cannabis during the 1st quarter worth approximately $166,000. Mackenzie Financial Corp purchased a new position in shares of Aurora Cannabis during the 2nd quarter worth approximately $113,000. Finally, Concurrent Investment Advisors LLC purchased a new position in shares of Aurora Cannabis during the 1st quarter worth approximately $90,000. 47.63% of the stock is owned by hedge funds and other institutional investors.

Aurora Cannabis Stock Down 0.9 %

ACB opened at $5.50 on Friday. The business has a 50 day moving average price of $5.90 and a two-hundred day moving average price of $6.06. The company has a quick ratio of 2.03, a current ratio of 3.76 and a debt-to-equity ratio of 0.08. The company has a market cap of $300.00 million, a PE ratio of -3.93 and a beta of 1.86. Aurora Cannabis has a 52 week low of $2.84 and a 52 week high of $9.35.

Aurora Cannabis (NASDAQ:ACB) last posted its quarterly earnings data on Wednesday, August 7th. The company reported ($0.11) EPS for the quarter, beating the consensus estimate of ($0.35) by $0.24. The firm had revenue of $67.27 million during the quarter, compared to the consensus estimate of $55.98 million. Aurora Cannabis had a negative return on equity of 7.00% and a negative net margin of 14.46%. As a group, research analysts anticipate that Aurora Cannabis will post -0.37 EPS for the current year.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.